Trials / Unknown
UnknownNCT01886248
Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate efficacy and safety of AT-III treatment in patients with hepatic veno-occlusive diseases following hematopoietic stem cell transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2021-08-01
- Completion
- 2021-08-01
- First posted
- 2013-06-25
- Last updated
- 2021-03-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01886248. Inclusion in this directory is not an endorsement.